Startup | February 10, 2022
Basf, Orbia Ventures invest in Israeli biotech startup
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
It would be the first protein-based alternative available in Israel
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The conflict is also triggering a widening public health emergency
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection
The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
Maria Soler Nunez appointed as Chief Quality Officer
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Subscribe To Our Newsletter & Stay Updated
